These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 24802297)

  • 1. Impact of albuminuria on the incidence of periprocedural myocardial injury in patients undergoing elective coronary stent implantation.
    Osugi N; Suzuki S; Ishii H; Yasuda Y; Shibata Y; Tatami Y; Ota T; Kawamura Y; Okumura S; Tanaka A; Inoue Y; Matsuo S; Murohara T
    Am J Cardiol; 2014 Jul; 114(1):42-6. PubMed ID: 24802297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the first-generation drug-eluting stent implantation on periprocedural myocardial injury in patients with stable angina pectoris.
    Okada T; Yoshikawa D; Ishii H; Matsumoto M; Hayakawa S; Matsudaira K; Tanaka M; Kumagai S; Hayashi M; Ando H; Amano T; Murohara T
    J Cardiol; 2012 Oct; 60(4):264-9. PubMed ID: 22738692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of low response to clopidogrel assessed with point-of-care assay to periprocedural myonecrosis in patients undergoing elective coronary stenting for stable angina pectoris.
    Cuisset T; Hamilos M; Sarma J; Sarno G; Wyffels E; Vanderheyden M; Barbato E; Bartunek J; De Bruyne B; Wijns W
    Am J Cardiol; 2008 Jun; 101(12):1700-3. PubMed ID: 18549843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, predictors and clinical significance of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention.
    Zhou Y; Chen Z; Ma J; Chen A; Lu D; Wu Y; Ren D; Zhang C; Dai C; Zhang Y; Qian J; Ge J
    J Cardiol; 2020 Sep; 76(3):309-316. PubMed ID: 32354492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of estimated glomerular filtration rate on periprocedural myocardial infarction in patients undergoing elective percutaneous coronary intervention.
    Vatankulu MA; Murat SN; Demircelik B; Turfan M; Sonmez O; Duran M; Bacaksiz A; Ornek E; Tasal A; Goktekin O
    Ren Fail; 2013 Aug; 35(7):931-5. PubMed ID: 23803143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periprocedural myocardial damage during percutaneous coronary intervention: a point-of-care platelet testing and intravascular ultrasound/virtual histology study.
    Michalak M; Huczek Z; Filipiak KJ; Roik MF; Kochman J; Opolski G
    Kardiol Pol; 2013; 71(4):325-33. PubMed ID: 23788337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of two-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention: a single-center, prospective, and randomized study.
    Veselka J; Zemánek D; Hájek P; Malý M; Adlová R; Martinkovicová L; Tesar D
    Am J Cardiol; 2009 Sep; 104(5):630-3. PubMed ID: 19699335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of chronic kidney disease with periprocedural myocardial injury after elective stent implantation: A single center prospective cohort study.
    Jerkic H; Letilovic T; Stipinovic M; Pocanic D; Catic J; Knotek M
    Medicine (Baltimore); 2016 Nov; 95(45):e5381. PubMed ID: 27828870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry.
    Jeremias A; Kleiman NS; Nassif D; Hsieh WH; Pencina M; Maresh K; Parikh M; Cutlip DE; Waksman R; Goldberg S; Berger PB; Cohen DJ;
    Circulation; 2008 Aug; 118(6):632-8. PubMed ID: 18645057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periprocedural myocardial infarction and injury in elective coronary stenting.
    Zeitouni M; Silvain J; Guedeney P; Kerneis M; Yan Y; Overtchouk P; Barthelemy O; Hauguel-Moreau M; Choussat R; Helft G; Le Feuvre C; Collet JP; Montalescot G;
    Eur Heart J; 2018 Apr; 39(13):1100-1109. PubMed ID: 29365133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial Injury after Percutaneous Coronary Intervention for In-Stent Restenosis Versus de novo Stenosis.
    Shimonaga T; Kurisu S; Watanabe N; Ikenaga H; Higaki T; Iwasaki T; Ishibashi K; Dohi Y; Fukuda Y; Kihara Y
    Intern Med; 2015; 54(18):2299-305. PubMed ID: 26370852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of high-density lipoprotein 3 cholesterol subfraction on periprocedural myocardial injury in patients who underwent elective percutaneous coronary intervention.
    Harada K; Kikuchi R; Suzuki S; Tanaka A; Aoki T; Iwakawa N; Kojima H; Hirayama K; Mitsuda T; Sumi T; Negishi Y; Ishii H; Murohara T
    Lipids Health Dis; 2018 Feb; 17(1):21. PubMed ID: 29391013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Multidetector Computed Tomography to Predict Periprocedural Myocardial Injury After Percutaneous Coronary Intervention for Chronic Total Occlusion.
    Usui E; Lee T; Murai T; Kanaji Y; Matsuda J; Araki M; Yonetsu T; Yamakami Y; Kimura S; Kakuta T
    Int Heart J; 2017 Feb; 58(1):16-23. PubMed ID: 28100874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of minor myocardial injury after successful percutaneous transluminal coronary angioplasty with or without stenting.
    Saadeddin SM; Habbab MA; Sobki SH; Ferns GA
    Med Sci Monit; 2000; 6(4):708-12. PubMed ID: 11208396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of Albuminuria on Cardiovascular Outcomes After Elective Percutaneous Coronary Intervention.
    Kunimura A; Ishii H; Uetani T; Harada K; Kataoka T; Takeshita M; Harada K; Okumura S; Shinoda N; Kato B; Kato M; Suzuki S; Amano T; Murohara T
    Am J Cardiol; 2016 Mar; 117(5):714-9. PubMed ID: 26772442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of chronic kidney disease on the incidence of peri-procedural myocardial injury in patients undergoing elective stent implantation.
    Kumagai S; Ishii H; Amano T; Uetani T; Kato B; Harada K; Yoshida T; Ando H; Kunimura A; Shimbo Y; Kitagawa K; Harada K; Hayashi M; Yoshikawa D; Matsubara T; Murohara T
    Nephrol Dial Transplant; 2012 Mar; 27(3):1059-63. PubMed ID: 21771758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine and risk of periprocedural myocardial infarction in patients undergoing coronary stenting.
    Verdoia M; Schaffer A; Barbieri L; Cassetti E; Di Giovine G; Marino P; De Luca G;
    J Cardiovasc Med (Hagerstown); 2015 Feb; 16(2):100-5. PubMed ID: 24625566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of platelet reactivity and C-reactive protein levels to occurrence of peri-procedural myocardial infarction in patients undergoing percutaneous coronary intervention (from the ARMYDA-CRP study).
    Patti G; Mangiacapra F; Ricottini E; Cannatà A; Cavallari I; Vizzi V; D'Ambrosio A; Dicuonzo G; Di Sciascio G
    Am J Cardiol; 2013 Jun; 111(12):1739-44. PubMed ID: 23538022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial).
    Bonaca MP; Wiviott SD; Sabatine MS; Buros J; Murphy SA; Scirica BM; Rifai N; Antman EM; Morrow DA
    Am J Cardiol; 2007 Feb; 99(3):344-8. PubMed ID: 17261395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of polyunsaturated fatty acids on periprocedural myocardial infarction after elective percutaneous coronary intervention.
    Suzuki A; Ando H; Takashima H; Kumagai S; Kurita A; Waseda K; Suzuki Y; Mizuno T; Harada K; Uetani T; Takahashi H; Yoshikawa D; Ishii H; Murohara T; Amano T
    EuroIntervention; 2014 Nov; 10(7):792-8. PubMed ID: 25415148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.